聯通(00762.HK)擬引入百度(09888.HK)小度科技終端產品
中國聯通(00762.HK)與百度(09888.HK)旗下生態鏈公司小度科技達成戰略合作,將在產品訂製、業務聯動、渠道合作、品牌聯合與生態共建等方面合作。聯通計劃全線引入小度多款標準化、訂製化的產品終端,包括小度智能學習平板等智能屏系列產品、小度WiFi6智能路由器等泛智能產品,打造涵蓋沃家固話、沃家神眼、沃家關愛、沃雲盤等體系的訂製化產品方案。
聯通表示,旗下1,000家核心自有營業廳將引入小度系列產品,並在全國範圍內50家高流量核心營業廳設立「小度&聯通」品牌專區,增強品牌聯動協同效應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.